DK0571921T3 - Cyclopeptider og deres anvendelse som resorptionsfremmende midler ved påføring på slimhinder - Google Patents

Cyclopeptider og deres anvendelse som resorptionsfremmende midler ved påføring på slimhinder

Info

Publication number
DK0571921T3
DK0571921T3 DK93108353.9T DK93108353T DK0571921T3 DK 0571921 T3 DK0571921 T3 DK 0571921T3 DK 93108353 T DK93108353 T DK 93108353T DK 0571921 T3 DK0571921 T3 DK 0571921T3
Authority
DK
Denmark
Prior art keywords
formula
basic
amino acid
physiologically tolerated
tolerated salts
Prior art date
Application number
DK93108353.9T
Other languages
Danish (da)
English (en)
Inventor
Juergen Dr Sandow
Walter Dr Duerckheimer
Guenter Dr Ditzinger
Hans-Peter Prof Merkle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0571921T3 publication Critical patent/DK0571921T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93108353.9T 1992-05-26 1993-05-24 Cyclopeptider og deres anvendelse som resorptionsfremmende midler ved påføring på slimhinder DK0571921T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4217350 1992-05-26

Publications (1)

Publication Number Publication Date
DK0571921T3 true DK0571921T3 (da) 1997-04-01

Family

ID=6459729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93108353.9T DK0571921T3 (da) 1992-05-26 1993-05-24 Cyclopeptider og deres anvendelse som resorptionsfremmende midler ved påføring på slimhinder

Country Status (18)

Country Link
US (1) US5565423A (enExample)
EP (1) EP0571921B1 (enExample)
JP (1) JPH0672899A (enExample)
KR (1) KR940005669A (enExample)
AT (1) ATE144991T1 (enExample)
AU (1) AU665676B2 (enExample)
CA (1) CA2096889A1 (enExample)
DE (1) DE59304389D1 (enExample)
DK (1) DK0571921T3 (enExample)
ES (1) ES2096140T3 (enExample)
FI (1) FI932351A7 (enExample)
GR (1) GR3021570T3 (enExample)
HU (1) HUT64776A (enExample)
IL (1) IL105795A (enExample)
NO (1) NO931888L (enExample)
NZ (1) NZ247680A (enExample)
TW (1) TW274552B (enExample)
ZA (1) ZA933629B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20070004743A1 (en) * 2002-02-25 2007-01-04 Xiao Linda L Intranasal administration of mc4-r agonists
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
CA2683517A1 (en) * 2007-04-23 2008-10-30 Bayer Schering Pharma Aktiengesellschaft Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
WO2010075416A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
MX355217B (es) 2011-11-18 2018-04-10 New Pharma Licence Holdings Ltd Derivados de polimixina.
HUE059544T2 (hu) 2013-05-22 2022-11-28 Spero Therapeutics Inc Polimixin-származékok és ezek alkalmazása kombinációs terápiában különbözõ antibiotikumokkal
CN107108699A (zh) 2014-11-26 2017-08-29 新药物许可控股有限公司 化合物
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
DK3810633T3 (da) 2018-06-25 2024-01-15 Spero Therapeutics Inc Forbindelser
CN113874045B (zh) * 2019-03-25 2023-11-24 国立大学法人筑波大学 细胞层渗透促进剂、药剂吸收辅助用组合物及药物组合物
CN116332993B (zh) * 2023-03-13 2026-02-13 遵义医科大学 一种氨基噻唑肟酰胺类化合物及其制备方法和应用
CN117649950B (zh) * 2024-01-29 2024-05-17 北京大学第三医院(北京大学第三临床医学院) 一种催产素药物作用动力学模型及其构建方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2124060B1 (enExample) * 1971-02-02 1974-04-12 Rhone Poulenc Sa
AU7753787A (en) * 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates

Also Published As

Publication number Publication date
AU3876693A (en) 1993-12-02
IL105795A (en) 1998-03-10
HUT64776A (en) 1994-02-28
AU665676B2 (en) 1996-01-11
NO931888L (no) 1993-11-29
TW274552B (enExample) 1996-04-21
CA2096889A1 (en) 1993-11-27
ES2096140T3 (es) 1997-03-01
US5565423A (en) 1996-10-15
JPH0672899A (ja) 1994-03-15
HU9301520D0 (en) 1993-09-28
ZA933629B (en) 1993-12-20
IL105795A0 (en) 1993-09-22
EP0571921A3 (enExample) 1994-01-12
EP0571921B1 (de) 1996-11-06
FI932351A0 (fi) 1993-05-24
EP0571921A2 (de) 1993-12-01
FI932351A7 (fi) 1993-11-27
NO931888D0 (no) 1993-05-25
DE59304389D1 (de) 1996-12-12
GR3021570T3 (en) 1997-02-28
ATE144991T1 (de) 1996-11-15
NZ247680A (en) 1995-07-26
KR940005669A (ko) 1994-03-22

Similar Documents

Publication Publication Date Title
TW274552B (enExample)
DK0948527T3 (da) Cylosporinderivater, fremstilling af disse og farmaceutiske præparater indeholdende disse
DE69216713D1 (de) Neue oral wirksame Elastase-Inhibitoren
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
GR3023719T3 (en) Trifluoromethylketone tripeptide derivatives
AU7535798A (en) Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
DE69213546D1 (de) Neue Peptid-Verbindungen und Verfahren zur Herstellung davon
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
FI883643A0 (fi) Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna.
WO1998019673A3 (en) Anti-viral agents and methods relating to the use thereof
DK0548790T3 (da) (1S)-hydroxyalkyloxapenem-3-carboxylsyrer og deres anvendelse som betalactamasehæmmere
DK1451184T3 (da) Dimere forbindelser og deres anvendelse som antivirale midler